Sagimet Biosciences Inc. stock rated Strong Buy on promising drug data and pipeline growth in acne and MASH. Click for this ...
Sagimet Biosciences, Inc. Class A ( ($SGMT) ) just unveiled an update. On 18 December 2025, Sagimet Biosciences updated its investor presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback